The global market is expected to enjoy a valuation of US$ 86.9 Million by the end of the year 2023, and further expand at a CAGR of 9.8% to reach a valuation of ~US$ 244.3 Million by the year 2033. According to the recent study by Future Market Insights, trolley mounted devices are leading the market with an expected share of about 38.7% in the year 2023, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 86.9 Million |
| Market Value 2023 | US$ 95.6 Million |
| Market Value 2033 | US$ 244.3 Million |
| CAGR 2023 to 2033 | 9.8% |
| Market Share of Top 5 Countries | 52.5% |
| Key Market Players List | Biodex Medical Systems, Inc., CAPINTEC, INC., Crystal Photonics GmBH, Devicor Medical Products, Inc (Mammotome), Dilon Technologies, Inc, Gamma Medical Technology, Intramedical Imaging, Intramedical Imaging, KUB Technologies, L'ACN - l'Accessorio Nucleare, Mammotome, NUCLEAR MEDSYSTEMS, Oncovision, and Southern Scientific Ltd. |
The global market for gamma probe devices is being driven by rising public knowledge of the advantages of gamma radiation over conventional detection methods like X-rays, as well as rising patient acceptance and surgeon use of it.
Gamma probe devices support radio guided surgery and diagnosis throughout the pre- and intra-operative phases.
For surgeons, it can be challenging to detect tissues like lymph nodes, tumours, and parathyroid glands within the human body. Therefore, using gamma probe devices properly could enable the surgeon to use a smaller incision to find the desired tissues. Demand will increase during the predicted period due to top cancer centres using gamma probes more routinely.
Increasing focus on product launch by market players, acquisitions they undertake, and surging application in cancer treatments are expected to drive the market growth over the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for gamma probe devices was around 1.4% of the overall ~US$ 6.4 Billion of the global radiotherapy devices market in 2022.
The sale of gamma probe devices expanded at a CAGR of 8.3% from 2015 to 2022.
The market for nuclear medicine has expanded due to the rising incidence of cancer worldwide, opening up enormous potential prospects. Healthcare professionals and regulatory agencies have been under pressure to enhance radioisotope manufacturing for use in therapeutic nuclear medications as the death rate from cancer has increased.
The surgeon and nuclear medicine doctor can employ intraoperative gamma probe systems, which are extremely sensitive, as a guidance to locate the radiolabelled sentinel lymph node.
For RSL, gamma probes are primarily used to find tiny, palpable breast lesions. Over the projection period, expanding use of gamma probes as nuclear medicine in oncology will present manufacturers with profitable prospects.
Market leaders are being prompted by growing demand for gamma probe devices in sentinel lymph node uptake operations to diversify their product offerings through tactical acquisitions of smaller businesses. Manufacturers are also concentrating on acquiring new companies to expand their industrial and commercial platforms and global distribution networks.
Thus, owing to the aforementioned factors, the global gamma probe devices market is expected to grow at a CAGR of 9.8% during the forecast period between 2023 and 2033.
H1-H2 Update
| Market Statistics | Details |
|---|---|
| Jan-Jun (H1), 2021 (A) | 7.86% |
| Jul-Dec (H2), 2021 (A) | 11.03% |
| Jan-Jun (H1),2022 Projected (P) | 7.45% |
| Jan-Jun (H1),2022 Outlook (O) | 7.79% |
| Jul-Dec (H2), 2022 Outlook (O) | 11.52% |
| Jul-Dec (H2), 2022 Projected (P) | 10.99% |
| Jan-Jun (H1), 2023 Projected (P) | 8.97% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 34↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | (-) 6↓ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 53↑ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | 49↑ |
Improvements in healthcare infrastructure together with increased medical spending by various government organizations have led to increasing number installations of innovative medical technology. The need for gamma probe instruments would go up as a result.
The use of robotic surgery has been prompted by the growing emphasis on striking a balance between cure and side effects, which calls for accurate target definition and control (intraoperative). Radio guided robotic surgery has recently been made easier with the introduction of DROP-IN gamma probes.
The click-on gamma probe's launch, meanwhile, is seen as a step toward the complete integration of radio guidance in surgery. The tethered (DROP-IN) gamma-probe concept enables the detector to match the degrees of freedom of the robotic instruments and facilitates autonomous control by the operating surgeon. This has been confirmed by robotic-assisted sentinel lymph node procedures and PSMA-guided salvage resection of lymph nodes.
The market for gamma probe devices is seeing profitable growth potential because of these developments.
Principal Consultant
The amount of product recalls and strict governmental controls hampered industry expansion. A company's financial situation, business, and operational outcomes gets negatively impacted by a product recall.
For instance, Devicor Medical Products Inc.’s 14 mm reusable probe called NeoProbe Bluetooth was recalled in April 2019 by Health Canada of the Government of Canada.
Another significant barrier to the market for gamma probe devices is anticipated to be patients' rising preference for cost-effective alternatives.
Only those who can afford the cost of the treatment can choose gamma probe devices. One of the main reasons limiting the growth of the gamma probe devices market is that not many healthcare facilities, such as small hospitals and clinics, can afford the high cost of the equipment.
| Country | The USA |
|---|---|
| Market Share (2023) | 22.1% |
| Market Share (2033) | 19.2% |
| BPS Analysis | -295 |
| Country | Germany |
|---|---|
| Market Share (2023) | 10.7% |
| Market Share (2033) | 9.2% |
| BPS Analysis | -146 |
| Country | UK |
|---|---|
| Market Share (2023) | 6.5% |
| Market Share (2033) | 5.9% |
| BPS Analysis | -68 |
| Country | China |
|---|---|
| Market Share (2023) | 6.7% |
| Market Share (2033) | 7.3% |
| BPS Analysis | 60 |
| Country | France |
|---|---|
| Market Share (2023) | 5.5% |
| Market Share (2033) | 5.2% |
| BPS Analysis | -38 |
The USA is set to dominate the globe with a total market share of about 22.1% in 2023, and is expected to continue to experience the same growth throughout the forecast period.
Major players in the US are concentrating on enhancing throughput, flexibility, and productivity. A rising cancer incidence, increased use of nuclear therapy, and technical advancements with new product debuts have all contributed to the market's expansion in the United States.
The market for nucleic therapies has increased in North America because of significant investments in RD and government support for the use of medical isotopes, which has strengthened the gamma probe sector.
Germany will hold a market share of nearly 10.7% in the global gamma probe devices market in 2023.
According to the research and knowledge department of the European Commission, there were around 2.7 million new cases of cancer, which includes all forms of cancer except non-melanoma skin cancer. Additionally, nearly 1.3 million fatalities occurred in Europe in 2020.
These statistics show that men are disproportionately more impacted by cancer than women, accounting for 54% of new cases and 56% of fatalities. As is commonly known, cancer mostly affects elderly people. The predictions for 2020 indicate that 76 percent of fatalities and 62 percent of new diagnoses occur in people over 65.
The Germany gamma probe device market is also being driven forward by the presence of well-established healthcare players and infrastructure as well as rising regional healthcare spending.
China will hold a share of around 6.7% in the global market, in 2023.
The ageing population within the region, good regulatory environment, adoption of new technologies, and high consumer disposable income, brings the market to expand within China.
The market in China is expected to rise over the next several years as a result of an increase in the frequency of chronic conditions that necessitate for surgical procedures, increasing unmet healthcare demand, and improved healthcare infrastructure.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Trolley mounted devices are set to hold a share of around 38.7% in the global market, in 2023.
Devices that are mounted on a trolley during procedures considerably increase portability and maneuverability. These tools typically enable data collection, graphical development, patient database organization, and spectrum analysis of any radioactive isotope that may be used. Over the course of the forecast period, these advantages are anticipated to contribute to the growth in the segment value for trolley-mounted devices.
Sentinel lymph node uptake applications are set to hold a market share of around 55.9% in the global market in 2023.
A sentinel node biopsy or sentinel lymph node biopsy (SLNB) is a surgical procedure for cancer patients. This procedure involves removal of the sentinel nodes, later transferred to a lab to be checked for malignant cells. A gamma probe is used during SLNB procedures as a tool to detect radiation in patients. It is mostly used in surgery and functions something like a tiny, directional Geiger counter. Sentinel node biopsy is thus, performed to determine extent of cancer spread.
Hospitals are expected to hold a market share of around 52.0% in the global market in 2023.
There is a growing global incidence of thyroid and glad disorders. Moreover, increasing cases of breast cancer are further propelling hospital in-patient rates, augmenting the segment growth over the forecast period. According to the American Hospital Association (AHA), there were approximately 6,146 hospitals in the United States as of 2018, and that number of new invasive breast cancer cases by 2020 were 276,480. During the forecast period, it is anticipated that this will create more growth opportunities for the gamma probe devices market.
In order to expand their client base and gain market share, medical device companies are concentrating on forming alliances with up-and-coming businesses.
At specialized scientific seminars and conferences, leading market participants advertise their products. It is anticipated that this marketing strategy would have a significant influence on overall expansion of the global market.
Recent Market Developments
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the gamma probe devices space, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2015 to 2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Modality, Application, End User, and Region |
| Key Companies Covered |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The United States, the United Kingdom, and Australia are leading the market.
The hospital industry holds high revenue potential.
The global market is estimated to capture a valuation of US$ 86.9 million in 2023.
The market is forecast to register a CAGR of 9.8% through 2033.
The market recorded a CAGR of 8.3% from 2018 to 2022.
1. Market- Executive Summary | Gamma Probe Devices Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Technology Evolution
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusion
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Thyroid and Cancer Epidemiology
4.2. Product Adoption/Usage Analysis
4.3. Product USPs
4.4. Promotional Strategies, By Key Players
4.5. Regulatory Scenario
4.6. Technology Assessment
4.7. PESTEL Analysis
4.8. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Industry Market Outlook
5.1.3. Global Radiotherapy Devices Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Adoption of Universal Health Coverage
5.2.2. Reimbursement Scenario
5.2.3. Regulatory Framework
5.2.4. Recent Advancements In Technology
5.2.5. Rising cancer cases
5.2.6. Growing Adoption of Gamma Probe Devices
5.2.7. Increasing Death Rate Due to Thyroid Cancer
5.2.8. Strategic Agreements Among Key Players to Increase Product Reach
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. 2022 Market Scenario
6.2. COVID19 and Impact Analysis
6.2.1. Revenue By Modality
6.2.2. Revenue By Application
6.2.3. Revenue By End User
6.2.4. Revenue By Country
7. Global Market Demand (in Volume Units) Analysis 2015 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Volume (Units) Analysis, 2015 to 2022
7.2. Current and Future Market Volume (units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Modality
8.2. Pricing Break-up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value US$ Million) Analysis 2015 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2015 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Modality
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) & Volume (Units) Analysis By Modality, 2015 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Modality, 2023 to 2033
10.3.1. Hand Held Device
10.3.2. Benchtop Device
10.3.3. Trolley Mounted Device
10.4. Market Attractiveness Analysis By Modality
11. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Application, 2015 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
11.3.1. Thyroid Uptake
11.3.2. Sentinel Lymph Node Uptake
11.3.2.1. Breast Cancer
11.3.2.2. Melanoma
11.3.2.3. Colon Cancer
11.3.2.4. NSCLC
11.3.2.5. Renal Cancer
11.3.2.6. Others
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Specialty Centers and Clinics
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2015 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2023 to 2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East & Africa(MEA)
13.4. Market Attractiveness Analysis by Region
14. North America Market Analysis 2015 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2015 to 2022
14.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
14.4.1. By Country
14.4.1.1. US
14.4.1.2. Canada
14.4.2. By Modality
14.4.3. By Application
14.4.4. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Modality
14.5.3. By Application
14.5.4. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country Level Analysis & Forecast
14.9.1. USA Market Analysis
14.9.1.1. Introduction
14.9.1.2. Market Analysis and Forecast by Market Taxonomy
14.9.1.2.1. By Modality
14.9.1.2.2. By Application
14.9.1.2.3. By End User
14.9.2. Canada Market Analysis
14.9.2.1. Introduction
14.9.2.2. Market Analysis and Forecast by Market Taxonomy
14.9.2.2.1. By Modality
14.9.2.2.2. By Application
14.9.2.2.3. By End User
15. Latin America Market Analysis 2015 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis by Market Taxonomy, 2015 to 2022
15.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Argentina
15.4.1.4. Rest of Latin America
15.4.2. By Modality
15.4.3. By Application
15.4.4. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Modality
15.5.3. By Application
15.5.4. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis & Forecast
15.9.1. Brazil Market Analysis
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast by Market Taxonomy
15.9.1.2.1. By Modality
15.9.1.2.2. By Application
15.9.1.2.3. By End User
15.9.2. Mexico Market Analysis
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast by Market Taxonomy
15.9.2.2.1. By Modality
15.9.2.2.2. By Application
15.9.2.2.3. By End User
15.9.3. Argentina Market Analysis
15.9.3.1. Introduction
15.9.3.2. Market Analysis and Forecast by Market Taxonomy
15.9.3.2.1. By Modality
15.9.3.2.2. By Application
15.9.3.2.3. By End User
16. Europe Market Analysis 2015 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
16.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. United Kingdom.
16.4.1.5. Spain
16.4.1.6. BENELUX
16.4.1.7. Russia
16.4.1.8. Rest of Europe
16.4.2. By Modality
16.4.3. By Application
16.4.4. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Modality
16.5.3. By Application
16.5.4. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast
16.9.1. Germany Market Analysis
16.9.1.1. Introduction
16.9.1.2. Market Analysis and Forecast by Market Taxonomy
16.9.1.2.1. By Modality
16.9.1.2.2. By Application
16.9.1.2.3. By End User
16.9.2. Italy Market Analysis
16.9.2.1. Introduction
16.9.2.2. Market Analysis and Forecast by Market Taxonomy
16.9.2.2.1. By Modality
16.9.2.2.2. By Application
16.9.2.2.3. By End User
16.9.3. France Market Analysis
16.9.3.1. Introduction
16.9.3.2. Market Analysis and Forecast by Market Taxonomy
16.9.3.2.1. By Modality
16.9.3.2.2. By Application
16.9.3.2.3. By End User
16.9.4. United Kingdom. Market Analysis
16.9.4.1. Introduction
16.9.4.2. Market Analysis and Forecast by Market Taxonomy
16.9.4.2.1. By Modality
16.9.4.2.2. By Application
16.9.4.2.3. By End User
16.9.5. Spain Market Analysis
16.9.5.1. Introduction
16.9.5.2. Market Analysis and Forecast by Market Taxonomy
16.9.5.2.1. By Modality
16.9.5.2.2. By Application
16.9.5.2.3. By End User
16.9.6. BENELUX Market Analysis
16.9.6.1. Introduction
16.9.6.2. Market Analysis and Forecast by Market Taxonomy
16.9.6.2.1. By Modality
16.9.6.2.2. By Application
16.9.6.2.3. By End User
16.9.7. Russia Market Analysis
16.9.7.1. Introduction
16.9.7.2. Market Analysis and Forecast by Market Taxonomy
16.9.7.2.1. By Modality
16.9.7.2.2. By Application
16.9.7.2.3. By End User
17. South Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
17.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Thailand
17.4.1.3. Indonesia
17.4.1.4. Malaysia
17.4.1.5. Rest of South Asia
17.4.2. By Modality
17.4.3. By Application
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Modality
17.5.3. By Application
17.5.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country Level Analysis & Forecast
17.9.1. India Market Analysis
17.9.1.1. Introduction
17.9.1.2. Market Analysis and Forecast by Market Taxonomy
17.9.1.2.1. By Modality
17.9.1.2.2. By Application
17.9.1.2.3. By End User
17.9.2. Thailand Market Analysis
17.9.2.1. Introduction
17.9.2.2. Market Analysis and Forecast by Market Taxonomy
17.9.2.2.1. By Modality
17.9.2.2.2. By Application
17.9.2.2.3. By End User
17.9.3. Indonesia Market Analysis
17.9.3.1. Introduction
17.9.3.2. Market Analysis and Forecast by Market Taxonomy
17.9.3.2.1. By Modality
17.9.3.2.2. By Application
17.9.3.2.3. By End User
17.9.4. Malaysia Market Analysis
17.9.4.1. Introduction
17.9.4.2. Market Analysis and Forecast by Market Taxonomy
17.9.4.2.1. By Modality
17.9.4.2.2. By Application
17.9.4.2.3. By End User
18. East Asia Market Analysis 2015 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Modality
18.4.3. By Application
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. China Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Modality
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. Japan Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Modality
18.8.2.2.2. By Application
18.8.2.2.3. By End User
18.8.3. South Korea Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Modality
18.8.3.2.2. By Application
18.8.3.2.3. By End User
19. Oceania Market Analysis 2015 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
19.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Modality
19.4.3. By Application
19.4.4. By End User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Modality
19.5.3. By Application
19.5.4. By End User
19.6. Country Level Analysis & Forecast
19.6.1. Australia Market Analysis
19.6.1.1. Introduction
19.6.1.2. Market Analysis and Forecast by Market Taxonomy
19.6.1.2.1. By Modality
19.6.1.2.2. By Application
19.6.1.2.3. By End User
19.6.2. New Zealand Market Analysis
19.6.2.1. Introduction
19.6.2.2. Market Analysis and Forecast by Market Taxonomy
19.6.2.2.1. By Modality
19.6.2.2.2. By Application
19.6.2.2.3. By End User
20. Middle East and Africa Market Analysis 2015 to 2022and Forecast 2023 to 2033
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
20.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Türkiye
20.4.1.3. South Africa
20.4.1.4. North Africa
20.4.1.5. Rest of Middle East and Africa
20.4.2. By Modality
20.4.3. By Application
20.4.4. By End User
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Modality
20.5.3. By Application
20.5.4. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
20.9. Country Level Analysis & Forecast
20.9.1. GCC Countries Market Analysis
20.9.1.1. Introduction
20.9.1.2. Market Analysis and Forecast by Market Taxonomy
20.9.1.2.1. By Modality
20.9.1.2.2. By Application
20.9.1.2.3. By End User
20.9.2. Türkiye Market Analysis
20.9.2.1. Introduction
20.9.2.2. Market Analysis and Forecast by Market Taxonomy
20.9.2.2.1. By Modality
20.9.2.2.2. By Application
20.9.2.2.3. By End User
20.9.3. South Africa Market Analysis
20.9.3.1. Introduction
20.9.3.2. Market Analysis and Forecast by Market Taxonomy
20.9.3.2.1. By Modality
20.9.3.2.2. By Application
20.9.3.2.3. By End User
20.9.4. North Africa Market Analysis
20.9.4.1. Introduction
20.9.4.2. Market Analysis and Forecast by Market Taxonomy
20.9.4.2.1. By Modality
20.9.4.2.2. By Application
20.9.4.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
21.4.1. Regional footprint of Players
21.4.2. Product footprint of Players
21.4.3. Channel Footprint of Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Deep Dive
22.2.1. Biodex Medical Systems, Inc.
22.2.1.1. Overview
22.2.1.2. Product Portfolio
22.2.1.3. Key Financial
22.2.1.4. Sales Footprint
22.2.1.5. SWOT Analysis
22.2.1.6. Strategy Overview
22.2.1.6.1. Marketing Strategies
22.2.1.6.2. Product Strategies
22.2.1.6.3. Channel Strategies
22.2.2. CAPINTEC, INC.
22.2.2.1. Overview
22.2.2.2. Product Portfolio
22.2.2.3. Key Financial
22.2.2.4. Sales Footprint
22.2.2.5. SWOT Analysis
22.2.2.6. Strategy Overview
22.2.2.6.1. Marketing Strategies
22.2.2.6.2. Product Strategies
22.2.2.6.3. Channel Strategies
22.2.3. Crystal Photonics GmBH
22.2.3.1. Overview
22.2.3.2. Product Portfolio
22.2.3.3. Key Financial
22.2.3.4. Sales Footprint
22.2.3.5. SWOT Analysis
22.2.3.6. Strategy Overview
22.2.3.6.1. Marketing Strategies
22.2.3.6.2. Product Strategies
22.2.3.6.3. Channel Strategies
22.2.4. Devicor Medical Products, Inc (Mammotome)
22.2.4.1. Overview
22.2.4.2. Product Portfolio
22.2.4.3. Key Financial
22.2.4.4. Sales Footprint
22.2.4.5. SWOT Analysis
22.2.4.6. Strategy Overview
22.2.4.6.1. Marketing Strategies
22.2.4.6.2. Product Strategies
22.2.4.6.3. Channel Strategies
22.2.5. Dilon Technologies, Inc
22.2.5.1. Overview
22.2.5.2. Product Portfolio
22.2.5.3. Key Financial
22.2.5.4. Sales Footprint
22.2.5.5. SWOT Analysis
22.2.5.6. Strategy Overview
22.2.5.6.1. Marketing Strategies
22.2.5.6.2. Product Strategies
22.2.5.6.3. Channel Strategies
22.2.6. Gamma Medical Technology
22.2.6.1. Overview
22.2.6.2. Product Portfolio
22.2.6.3. Key Financial
22.2.6.4. Sales Footprint
22.2.6.5. SWOT Analysis
22.2.6.6. Strategy Overview
22.2.6.6.1. Marketing Strategies
22.2.6.6.2. Product Strategies
22.2.6.6.3. Channel Strategies
22.2.7. Intramedical Imaging
22.2.7.1. Overview
22.2.7.2. Product Portfolio
22.2.7.3. Key Financial
22.2.7.4. Sales Footprint
22.2.7.5. SWOT Analysis
22.2.7.6. Strategy Overview
22.2.7.6.1. Marketing Strategies
22.2.7.6.2. Product Strategies
22.2.7.6.3. Channel Strategies
22.2.8. Intramedical Imaging
22.2.8.1. Overview
22.2.8.2. Product Portfolio
22.2.8.3. Key Financial
22.2.8.4. Sales Footprint
22.2.8.5. SWOT Analysis
22.2.8.6. Strategy Overview
22.2.8.6.1. Marketing Strategies
22.2.8.6.2. Product Strategies
22.2.8.6.3. Channel Strategies
22.2.9. KUB Technologies
22.2.9.1. Overview
22.2.9.2. Product Portfolio
22.2.9.3. Key Financial
22.2.9.4. Sales Footprint
22.2.9.5. SWOT Analysis
22.2.9.6. Strategy Overview
22.2.9.6.1. Marketing Strategies
22.2.9.6.2. Product Strategies
22.2.9.6.3. Channel Strategies
22.2.10. L'ACN - l'Accessorio Nucleare
22.2.10.1. Overview
22.2.10.2. Product Portfolio
22.2.10.3. Key Financial
22.2.10.4. Sales Footprint
22.2.10.5. SWOT Analysis
22.2.10.6. Strategy Overview
22.2.10.6.1. Marketing Strategies
22.2.10.6.2. Product Strategies
22.2.10.6.3. Channel Strategies
22.2.11. Mammotome
22.2.11.1. Overview
22.2.11.2. Product Portfolio
22.2.11.3. Key Financial
22.2.11.4. Sales Footprint
22.2.11.5. SWOT Analysis
22.2.11.6. Strategy Overview
22.2.11.6.1. Marketing Strategies
22.2.11.6.2. Product Strategies
22.2.11.6.3. Channel Strategies
22.2.12. NUCLEAR MEDSYSTEMS
22.2.12.1. Overview
22.2.12.2. Product Portfolio
22.2.12.3. Key Financial
22.2.12.4. Sales Footprint
22.2.12.5. SWOT Analysis
22.2.12.6. Strategy Overview
22.2.12.6.1. Marketing Strategies
22.2.12.6.2. Product Strategies
22.2.12.6.3. Channel Strategies
22.2.13. Oncovision
22.2.13.1. Overview
22.2.13.2. Product Portfolio
22.2.13.3. Key Financial
22.2.13.4. Sales Footprint
22.2.13.5. SWOT Analysis
22.2.13.6. Strategy Overview
22.2.13.6.1. Marketing Strategies
22.2.13.6.2. Product Strategies
22.2.13.6.3. Channel Strategies
22.2.14. Southern Scientific Ltd.
22.2.14.1. Overview
22.2.14.2. Product Portfolio
22.2.14.3. Key Financial
22.2.14.4. Sales Footprint
22.2.14.5. SWOT Analysis
22.2.14.6. Strategy Overview
22.2.14.6.1. Marketing Strategies
22.2.14.6.2. Product Strategies
22.2.14.6.3. Channel Strategies
23. Assumptions and Acronyms Used
24. Research Methodolog
Explore Healthcare Insights
View Reports
Gamma Probe Devices Market
